PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

185.7B

Vuru Grade

75.13/100

Current Price

$29.28
-0.11 (-0.37%)

Growth Price

$30.44
Fairly valued

Stability Price

$11.59
Overvalued by 60.40%

Company Metrics

  • 18.46 P/E
  • 3.70 P/S
  • 2.43 P/B
  • 1.592 EPS
  • 11.61% Cash ROIC
  • 1.39 Cash Ratio
  • 1.02 / 3.47 % Dividend
  • 23.11M Avg. Vol.
  • 6.34B Shares
  • 185.7B Market Cap.

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

3 Reasons Pfizer Inc.'s Stock Could Fall
Motley Fool - Aug 27, 2014
Pfizer (NYSE: PFE ) may be the largest pharmaceutical company in the world, but size isn't everything when it comes to developing and selling drugs.
3 Reasons Pfizer Inc.'s Stock Could Rise
Motley Fool - Aug 19, 2014
Pfizer (NYSE: PFE ) , arguably the preeminent pharmaceutical company in the world, continues to pump out billions in free cash flow annually, deliver delectable gross margins, and pay out an annual dividend that puts the S&P 500 average yield of 2% to ...
AstraZeneca rises as investors bet on revival of Pfizer deal
Philly.com - Aug 30, 2014
According to reports July 29, 2014, Pfizer Inc.. the second-largest U.S. pharmaceutical maker, posted a 79 percent drop in second quarter profits, but beat analyst expectations.
UK Stocks Rise as AstraZeneca Gains on Pfizer Report - Businessweek
AstraZeneca And Pfizer Can Commence Merger Talks Again - Bidness ETC
Pfizer Inc. (PFE), General Electric Company (GE) and Eaton Corp plc (ETN): Top ...
StockWise Daily - 6 hours ago
According to the 13F form filed by Levin Capital Strategies, managed by John A. Levin, Pfizer Inc. (NYSE:PFE), General Electric Company (NYSE:GE) and Eaton Corp plc (NYSE:ETN) are among the top holdings of the fund.
Pfizer: Prescription For A Strong Dividend Yield (PFE)
Seeking Alpha (registration) - 10 hours ago
Pfizer (NYSE:PFE) looks like a good buy due to its (1) strong balance sheet, (2) low valuation, and (3) attractive dividend yield.
5 Things Pfizer Inc.'s Management Wants You to Know
Motley Fool - Aug 12, 2014
For the quarter, Pfizer reported that revenue slipped 2%, or $200 million, to $12.77 billion. Profits were also a mixed tale with Pfizer's adjusted income dipping 6% and its adjusted EPS rising 4%. The company also lowered its full-year revenue ...
Pfizer Inc. (PFE): Trouble Ahead For The Stock - ETF Daily News
Intel Corporation (NASDAQ:INTC), Pfizer Inc. (NYSE:PFE), Microsoft Corporation ... - US Trade Media
AstraZeneca now tougher target for Pfizer
The News Journal - Aug 22, 2014
Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.
AstraZeneca is tougher Pfizer target as possible bid looms - Chicago Tribune
Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy
Bidness ETC - Aug 27, 2014
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) announced yesterday that they have partnered to conduct trials investigating the combined efficacy of the former's lung-cancer drug, Xalkori, along with the latter's experimental drug, Pembrolizumab ...
Pfizer to test Xalkori lung cancer drug with Merck immunotherapy - Reuters UK
Growth Prospects Remain Strong For Pfizer
Seeking Alpha (registration) - Aug 27, 2014
These changes have allowed Pfizer to improve its cash position, which is vital for the strategic growth plans of the company in the long run. These transactions also resulted in better profitability for the company in 2013, clearly showing that the ...
Good News For Pfizer And GSK: E-Cigarettes To Be Strictly Regulated
Bidness ETC - Aug 25, 2014
The AHA mentioned that “proven cessation methods” like Nicorette Gum and the NicoDerm CQ patch from GlaxoSmithKline Plc (GSK), or Chantix from Pfizer Inc. (PFE) should be recommended for smokers looking to quit. However, Pfizer's Chantix sales have ...